| P/E (FY) | — | Sales (TTM) | $638.8M |
| Earnings (TTM) | -$22.7M | ROE | −5.78% |
| Net Margin | −6.77% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 7.57% |
10x Genomics develops and sells instruments, consumables, and software for analyzing biological systems across the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. Its Chromium platform enables single cell analysis with microfluidic chips, instruments, and RNA and methylation kits, while its Visium platform supports spatial analysis using high density DNA arrays to encode the physical location of biological analytes within a sample, including the Visium CytAssist instrument.
| Market Cap | $5.78B | Trading Days | 1723 |
| 52W High | 49.50 |
| 52W Low | 11.16 |
| % Off High | −6.42% |
| YTD | 184.00% | 1Y | 230.86% |
| 3Y | −26.45% | 5Y | −74.84% |
| Since incept. (ann.) | −1.87% |
Americas 32% · US 31% · EMEA 14% · Asia Pacific 11% · …
| Ann. Volatility (1Y) | 69.68% | Ann. Volatility (3Y) | 67.12% |
| Sharpe (1Y) | 2.03 | Sharpe (3Y) | 0.18 |
| Max Drawdown (1Y) | −28.03% | Max Drawdown (3Y) | −88.66% |
| Beta (3Y, vs SPY) | 1.89 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| BIO | BIO-RAD LABORATORIES, INC. | $9.05B | 11.8 |
| BRKR | BRUKER CORP | $9.37B | — |
| AVTR | Avantor, Inc. | $9.82B | — |
| RVTY | REVVITY, INC. | $12.65B | 54.8 |
| ALMR | Alamar Biosciences, Inc. | $1.69B | — |
| MTD | METTLER TOLEDO INTERNATIONAL INC/ | $28.05B | 33.0 |
| ILMN | ILLUMINA, INC. | $29.48B | 35.7 |
| EYPT | EyePoint, Inc. | $999.4M | — |
| WAT | WATERS CORP /DE/ | $37.26B | 35.3 |
| A | AGILENT TECHNOLOGIES, INC. | $39.63B | 30.7 |
| CTKB | Cytek Biosciences, Inc. | $565.6M | — |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
| $434.8M |
| — |